Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 59.82% vs 3.36% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 3,014.02% vs -84.55% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 1,731.23% vs -80.93% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 40.00% vs 100.00% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Kaken Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 56.61% vs 5.44% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 59.82% vs 3.36% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 1,031.23% vs 83.74% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 3,014.02% vs -84.55% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 2,830.05% vs -136.67% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 1,731.23% vs -80.93% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 7.69% vs 18.18% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 40.00% vs 100.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






